Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $485,000 | +42.2% | 32,085 | +11.7% | 0.00% | – |
| Q1 2022 | $341,000 | -29.3% | 28,735 | -3.4% | 0.00% | – |
| Q4 2021 | $482,000 | -54.8% | 29,754 | -20.3% | 0.00% | -100.0% |
| Q3 2021 | $1,066,000 | -15.4% | 37,354 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $1,260,000 | +11.8% | 37,271 | +0.0% | 0.00% | 0.0% |
| Q1 2021 | $1,127,000 | -39.2% | 37,260 | -0.5% | 0.00% | -50.0% |
| Q4 2020 | $1,853,000 | -14.4% | 37,439 | -33.6% | 0.00% | -33.3% |
| Q3 2020 | $2,164,000 | -13.4% | 56,381 | -2.6% | 0.00% | 0.0% |
| Q2 2020 | $2,500,000 | +55.0% | 57,892 | -6.4% | 0.00% | +50.0% |
| Q1 2020 | $1,613,000 | – | 61,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 2,194,278 | $108,639,000 | 6.47% |
| Memorial Sloan Kettering Cancer Center | 216,916 | $10,740,000 | 4.55% |
| Burrage Capital Management LLC | 114,962 | $5,692,000 | 4.34% |
| MPM BioImpact LLC | 674,582 | $33,398,000 | 2.88% |
| First Light Asset Management, LLC | 635,652 | $31,471,000 | 2.33% |
| Cormorant Asset Management, LP | 1,661,647 | $82,268,000 | 1.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 219,419 | $10,863,000 | 1.05% |
| ORACLE INVESTMENT MANAGEMENT INC | 126,342 | $6,255,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 131,016 | $6,487,000 | 0.58% |
| Artal Group S.A. | 285,028 | $14,112,000 | 0.30% |